ResMed Inc. (RMD)
NYSE: RMD · IEX Real-Time Price · USD
218.74
+0.17 (0.08%)
May 20, 2024, 4:00 PM EDT - Market closed
ResMed Employees
ResMed had 10,140 employees on June 30, 2023. The number of employees increased by 1,980 or 24.26% compared to the previous year.
Employees
10,140
Change (1Y)
1,980
Growth (1Y)
24.26%
Revenue / Employee
$452,087
Profits / Employee
$94,515
Market Cap
32.13B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
Jun 30, 2022 | 8,160 | 190 | 2.38% |
Jun 30, 2021 | 7,970 | 200 | 2.57% |
Jun 30, 2020 | 7,770 | 530 | 7.32% |
Jun 30, 2019 | 7,240 | 1,300 | 21.89% |
Jun 30, 2018 | 5,940 | -140 | -2.30% |
Jun 30, 2017 | 6,080 | 830 | 15.81% |
Jun 30, 2016 | 5,250 | 910 | 20.97% |
Jun 30, 2015 | 4,340 | 240 | 5.85% |
Jun 30, 2014 | 4,100 | 200 | 5.13% |
Jun 30, 2013 | 3,900 | 200 | 5.41% |
Jun 30, 2012 | 3,700 | 250 | 7.25% |
Jun 30, 2011 | 3,450 | 250 | 7.81% |
Jun 30, 2010 | 3,200 | 300 | 10.34% |
Jun 30, 2009 | 2,900 | 200 | 7.41% |
Jun 30, 2008 | 2,700 | 0 | - |
Jun 30, 2007 | 2,700 | 200 | 8.00% |
Jun 30, 2006 | 2,500 | 573 | 29.74% |
Jun 30, 2005 | 1,927 | 407 | 26.78% |
Jun 30, 2004 | 1,520 | 56 | 3.83% |
Jun 30, 2003 | 1,464 | 214 | 17.12% |
Jun 30, 2002 | 1,250 | 297 | 31.16% |
Jun 30, 2001 | 953 | 348 | 57.52% |
Jun 30, 2000 | 605 | 104 | 20.76% |
Jun 30, 1999 | 501 | 111 | 28.46% |
Jun 30, 1998 | 390 | 106 | 37.32% |
Jun 30, 1997 | 284 | 55 | 24.02% |
Jun 30, 1996 | 229 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Koninklijke Philips | 69,656 |
GE HealthCare Technologies | 51,000 |
Cardinal Health | 48,000 |
ICON PLC | 41,100 |
Haleon | 25,408 |
Zimmer Biomet Holdings | 18,000 |
Mettler-Toledo International | 17,300 |
West Pharmaceutical Services | 10,600 |
RMD News
- 4 days ago - ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy - GlobeNewsWire
- 23 days ago - S&P 500 Gains and Losses Today: Resmed Soars Amid Strong Demand for Sleep Devices - Investopedia
- 24 days ago - ResMed Stock Soars After Strong Earnings. Wall Street Thinks It Can Do Even Better. - Barrons
- 24 days ago - ResMed tops quarterly profit estimates on strong demand for sleep apnea devices - Reuters
- 25 days ago - ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024 - GlobeNewsWire
- 6 weeks ago - ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024 - GlobeNewsWire
- 2 months ago - ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis - GlobeNewsWire
- 2 months ago - Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed's Smallest Full-Face CPAP Mask - GlobeNewsWire